CASP3 and pulmonary arterial hypertension: Furthermore, this study found that effective anti-inflammatory therapy was promising to combat pulmonary hypertension, activating the apoptotic executor signaling axis (p53-Bax-Bcl-2-caspase 3) and potentiated PASMC apoptosis.